EXIMIAS PHARMACEUTICAL CORPORATION
Eximias Pharmaceutical Corporation is a healthcare and pharmaceutical company. It focuses on the acquisition, development, and commercialization of unique oncology and infectious disease products. The company has three novel, late-stage products, THYMITAQ(R) and ORATAQ(TM) for oncology, and MACROTAC(TM) for oncology and infectious disease. THYMITAQ(R), the company's flagship product, is being evaluated in a Phase III ETHECC(C) trial for the treatment of patients with unresectable liver cancer. Eximias Pharmaceutical Corporation was founded in 1997. The company was founded by YM BioSciences on April 1, 2006.
EXIMIAS PHARMACEUTICAL CORPORATION
Industry:
Biotechnology Health Care Medical
Founded:
1997-01-01
Address:
Berwyn, Pennsylvania, United States
Country:
United States
Total Employee:
1+
Status:
Active
Total Funding:
0
Current Employees Featured
Investors List
Birchmere Ventures
Birchmere Ventures investment in Seed Round - Eximias Pharmaceutical Corporation
More informations about "Eximias Pharmaceutical Corporation"
Eximias Pharmaceutical - 2025 Company Profile - Tracxn
Eximias Pharmaceutical is an acqui-hired company based in Berwyn (United States), founded in 1998 by Elizabeth Corsi. It operates as a Small molecule drugs for cancer & infectious …See details»
YM BioSciences Completes Acquisition Of EXIMIAS Pharmaceutical …
May 10, 2006 Mr. Updike brings over 17 years experience in the areas of business development, sales and marketing. Prior to Eximias, Mr. Updike was a Senior Director of Global Business …See details»
Organization | Eximias Pharmaceutical
Eximias Pharmaceutical Report issue. For profit Phase 3. Founded: Berwyn PA United States ... Organization Overview. First Clinical Trial. 2000 NCT00012324. First Marketed Drug. None ...See details»
EXIMIAS Pharmaceutical - Products, Competitors, Financials, …
EXIMIAS Pharmaceutical is a Berwyn, Pennsylvania-based Healthcare company. Use the CB Insights Platform to explore EXIMIAS Pharmaceutical's full profile. EXIMIAS Pharmaceutical - …See details»
Eximias Pharmaceutical Corp. - Drug pipelines, Patents, Clinical …
May 8, 2025 Explore Eximias Pharmaceutical Corp. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 2 news, and 2 literature, Drug:Nolatrexed Dihydrochloride. …See details»
Eximias Pharmaceutical Corp - Company Profile and News
Company profile page for Eximias Pharmaceutical Corp including stock price, company news, executives, board members, and contact informationSee details»
Eximias Pharmaceutical Corporation | Biotechnology, Health Care, …
Eximias Pharmaceutical Corporation was founded in 1997. The company was founded by YM BioSciences on April 1, 2006. #People #Financial #More. EXIMIAS PHARMACEUTICAL …See details»
EXIMIAS Pharmaceutical Corp.
EXIMIAS Pharmaceutical Corp., is located at Berwyn, PA and is a privately-held pharmaceutical company that engages in the acquisition, development and commercialization of products for …See details»
Eximias Pharmaceutical Corp. - BioCentury Company Profiles - BCIQ
Oct 1, 2007 Eximias Pharmaceutical Corp. - BioCentury Company Profiles for the biopharma industrySee details»
EXIMIAS Pharmaceutical Corporation - VentureRadar
Avidas Pharmaceuticals USA n/a n/a. Ardena Belgium n/a Ardena is a fully integrated Contract Development & Manufacturing Organization (CDMO) with a core focus on bringing molecules …See details»
Eximias Pharmaceutical Corporation acquired by YM BioSciences
Apr 1, 2006 Acquiring Organization: YM BioSciences YM BioSciences is a life sciences product development company that identifies and advances a diverse portfolio of promising cancer …See details»
Elizabeth Corsi – Eximias Pharmaceutical Corporation
Oct 14, 2002 ELIZABETH A. CORSI, President, Chief Executive Officer and Director of EXIMIAS Pharmaceutical Corporation, has spent over 17 years in multinational …See details»
Eximias Pharmaceutical Corporation - Company Information
Find useful insights on Eximias Pharmaceutical Corporation's company details, tech stack, news alerts, competitors and more. Use 6sense to connect with top decision-makers at Eximias …See details»
New Jersey Biotech, Pharma & Medical Device Company List
Sterile pharmaceutical company that develops injectable and ophthalmic drugs: Oticon : Somerset, NJ: Hearing Aids: Prinston Pharmaceutical : Somerset, NJ: Generics: Sannova …See details»
Eximias Pharmaceutical Corporation - Contacts, Employees, Board …
Eximias Pharmaceutical Corporation has 1 current employee profile, Member Of The Board Of Directors Alan Y. Kwan. Alan Y. Kwan Member Of The Board Of Directors Browse By: …See details»
70 Silton Road, Unit 18, Woodbridge, ON L4L 8B9 - OpenCorpData
Jun 14, 2006 EXIR PHARMA INC. (Corporation# 6584039) is a federal corporation entity registered with Corporations Canada. The incorporation date is June 14, 2006. The principal …See details»
American Association of Pharmaceutical Scientists - association …
Association Insight was designed to empower associations and partners through access to industry data. Starting as a print directory nearly 50 years ago, Association Insight, launched in …See details»
Roche pharmaceuticals announces investment in Pennsylvania
Apr 22, 2025 The company — like cross-town competitor Novartis — has deep ties to the U.S. market and said it currently employs 25,000 people and operates 15 R&D centers and 13 …See details»
Exir Pharma Company Profile | Management and Employees List
The company specializes in herbal formulas, vitamins and nutritional supplements as well as organic skin and hair care products and external wound repair supplements. Our team of …See details»
Pharmaceutical company to build manufacturing facility in NC
5 days ago Last week, it was announced that Genentech, a founding company in the biotech industry, plans to build a $700 million, 700,000 square-foot manufacturing facility in Holly …See details»